SectorPharmaceutical
Established Date11/06/2018
Listing Date08/10/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees44
Fiscal Year Ends31/12
Security TypeCommon stock
Office address321 Harrison Avenue, Boston, Massachusetts 02118
Business
IntroductionPyxis Oncology, Inc., was incorporated in Delaware on June 11, 2018. The company is a clinical-stage oncology company focused on developing a multi-modal portfolio of next-generation therapies to target difficult-to-treat cancers and improve the quality of life of patients. The goal of the product candidates developed by the company is to directly kill tumor cells and address the underlying pathology caused by cancer, resulting in uncontrolled proliferation and immune evasion.
